ZimVie (NASDAQ:ZIMV) Trading 9.2% Higher

ZimVie Inc. (NASDAQ:ZIMVGet Rating)’s share price shot up 9.2% during mid-day trading on Monday . The company traded as high as $19.53 and last traded at $19.49. 15,029 shares traded hands during trading, a decline of 96% from the average session volume of 425,462 shares. The stock had previously closed at $17.84.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. assumed coverage on shares of ZimVie in a report on Friday, June 17th. They issued a “neutral” rating and a $20.00 target price for the company.

ZimVie Stock Down 1.8 %

The company has a debt-to-equity ratio of 0.76, a current ratio of 2.33 and a quick ratio of 1.41. The stock has a 50 day moving average of $18.04.

ZimVie (NASDAQ:ZIMVGet Rating) last released its earnings results on Wednesday, August 10th. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.16. The company had revenue of $234.56 million for the quarter. The company’s revenue was down 11.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.71 earnings per share. On average, analysts expect that ZimVie Inc. will post 1.96 EPS for the current year.

ZimVie Company Profile

(Get Rating)

ZimVie Inc, a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies.

Featured Articles

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.